Generic Keppra Set For Launch In November 2008 After UCB Settles
This article was originally published in The Pink Sheet Daily
Executive Summary
Mylan could launch generic versions of the antiepileptic Nov. 1, 2008, two months ahead of anticipated exclusivity expiry of levetiracetam.
You may also be interested in...
UCB’s Vimpat Gets FDA Approval For Epileptic Seizures
Belgian specialty pharma hopes to launch drug in U.S. early next year; says blockbuster sales could follow.
UCB’s Vimpat Gets FDA Approval For Epileptic Seizures
Belgian specialty pharma hopes to launch drug in U.S. early next year; says blockbuster sales could follow.
UCB’s Keppra XR Wins FDA Approval
Extended-release tabs set to beat Keppra generics to pharmacy shelves.